| scholarly article | Q13442814 |
| P50 | author | Roy Curtiss | Q7372720 |
| P2093 | author name string | Kelly SM | |
| P2860 | cites work | The effects of biochemical mutation on the virulence of Bacterium typhosum; the loss of virulence of certain mutants | Q39970590 |
| The role of cAMP in flagellation of Salmonella typhimurium | Q39991343 | ||
| Cyclic nucleotide activity in gastrointestinal tissues and fluids | Q40062531 | ||
| Immune system of the gastrointestinal tract | Q40153730 | ||
| Mutation in the crp gene of Salmonella typhimurium which interferes with inducer exclusion. | Q40333295 | ||
| Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues | Q40657187 | ||
| Safety and Antigenicity of Typhoid-Shigella sonnei Vaccine (Strain 5076-1C) | Q40829610 | ||
| Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine | Q40897058 | ||
| Biological Containment and Cloning Vector Transmissibility | Q40901113 | ||
| A common mucosal immunologic system involving the bronchus, breast and bowel | Q41808590 | ||
| Evidence for related virulence sequences in plasmids of Salmonella dublin and Salmonella typhimurium | Q41824790 | ||
| Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems | Q44701798 | ||
| Phage P22-mutants with increased or decreased transduction abilities | Q45252565 | ||
| Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine | Q48245954 | ||
| Interaction of cAMP receptor protein with the ompA gene, a gene for a major outer membrane protein of Escherichia coli | Q48409306 | ||
| 1984 Kreshover lecture. Genetic analysis of Streptococcus mutans virulence and prospects for an anticaries vaccine | Q48532898 | ||
| An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice | Q50202253 | ||
| The colonization of Peyer's patches by a strain of Salmonella typhimurium cured of the cryptic plasmid | Q50203318 | ||
| Salmonella typhimurium mutants affecting establishment of lysogeny | Q50232993 | ||
| Cyclic adenosine monophosphate in bacteria | Q50240174 | ||
| Fimbriation, pellicle formation and the amount of growth of salmonellas in broth | Q50246897 | ||
| Pleiotropic deficiency of carbohydrate utilization in an adenyl cyclase deficient mutant of Escherichia coli. | Q54782078 | ||
| Sites of allosteric shift in the structure of the cyclic AMP receptor protein. | Q54795893 | ||
| Virulence-associated plasmids of Salmonella serotype Typhimurium in experimental murine infection | Q68224130 | ||
| Effect of age and diet on cyclic nucleotide concentrations in the intestinal mucosa of developing rats | Q70138245 | ||
| Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin | Q72815583 | ||
| Transport of trehalose in Salmonella typhimurium | Q28360464 | ||
| Linkage map of Salmonella typhimurium, Edition VI | Q33628173 | ||
| Parental functions during conjugation in Escherichia coli K-12 | Q33850382 | ||
| Hybridization between Escherichia coli and Shigella. | Q33972142 | ||
| Ultraviolet-induced genetic recombination in a partially diploid strain of Escherichia coli | Q33984871 | ||
| Cyclic adenosine 5'-monophosphate in Escherichia coli | Q34071953 | ||
| Enterochelin (enterobactin): virulence factor for Salmonella typhimurium | Q34082056 | ||
| Positive selection for loss of tetracycline resistance. | Q34147960 | ||
| Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics | Q34177240 | ||
| Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium | Q34179063 | ||
| Transduction of linked genetic characters of the host by bacteriophage P1. | Q34237612 | ||
| Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans | Q34564835 | ||
| CHROMOSOMAL ABERRATIONS ASSOCIATED WITH MUTATIONS TO BACTERIOPHAGE RESISTANCE IN ESCHERICHIA COLI. | Q35162398 | ||
| The route of enteric infection in normal mice | Q36273394 | ||
| Selection for loss of tetracycline resistance by Escherichia coli. | Q36322268 | ||
| Association of adhesive, invasive, and virulent phenotypes of Salmonella typhimurium with autonomous 60-megadalton plasmids | Q36336985 | ||
| Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants | Q36417093 | ||
| Cyclic AMP-dependent synthesis of fimbriae in Salmonella typhimurium: effects of cya and pts mutations | Q36419657 | ||
| Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain | Q36431701 | ||
| Requirement of adenosine 3', 5'-cyclic phosphate for flagella formation in Escherichia coli and Salmonella typhimurium | Q36786366 | ||
| Plasmid-associated virulence of Salmonella typhimurium | Q37008636 | ||
| Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin. | Q37026113 | ||
| Epidemiology of virulence-associated plasmids and outer membrane protein patterns within seven common Salmonella serotypes. | Q37048365 | ||
| The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid | Q37048925 | ||
| Plasmid-cured Salmonella enteritidis AL1192 as a candidate for a live vaccine | Q37049610 | ||
| Adenosine 3':5'-cyclic monophosphate concentration in the bacterial host regulates the viral decision between lysogeny and lysis | Q37487236 | ||
| Isolation and characterization of cAMP suppressor mutants of Escherichia coli K12 | Q39108776 | ||
| Origin and differentiation of lymphocytes involved in the secretory IgA responses | Q39448606 | ||
| Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
| Generation of deletions in the 3'-flanking sequences of the Escherichia coli crp gene that induce cyclic AMP suppressor functions | Q39955742 | ||
| The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants | Q39970330 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 3035-3043 | |
| P577 | publication date | 1987-12-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic | |
| P478 | volume | 55 |
| Q36483591 | A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice |
| Q37004624 | A Salmonella typhimurium virulence gene linked to flg. |
| Q40375203 | A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys |
| Q45769445 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity |
| Q39516638 | A functional cra gene is required for Salmonella enterica serovar typhimurium virulence in BALB/c mice |
| Q44714478 | A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium |
| Q33757861 | A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae |
| Q38443037 | A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge |
| Q36950003 | A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines |
| Q34286908 | A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. |
| Q36506067 | Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. |
| Q35047221 | Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors |
| Q33619042 | Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain |
| Q30953219 | Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus |
| Q50135642 | Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent? |
| Q61818475 | Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains |
| Q43685671 | Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice |
| Q50103381 | Attenuated Salmonella typhimurium prevents the establishment of unresectable hepatic metastases and improves survival in a murine model |
| Q36657731 | Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma |
| Q50082483 | Attenuated aroA Salmonella enterica serovar Typhimurium does not induce inflammatory response and early protection of gnotobiotic pigs against parental virulent LT2 strain |
| Q34001774 | Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs |
| Q71031986 | Auxotrophic vaccines for tuberculosis |
| Q45787068 | Avirulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination |
| Q39649727 | Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen |
| Q48529701 | Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens |
| Q29615329 | Carbon catabolite repression in bacteria: many ways to make the most out of nutrients |
| Q35561471 | Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants |
| Q36971527 | Characterization and protective properties of attenuated mutants of Salmonella choleraesuis |
| Q36951389 | Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis |
| Q40429609 | Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo |
| Q50140997 | Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium delta cya delta crp: persistence, stability and immune response in swine |
| Q35426022 | Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies |
| Q36136610 | Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium |
| Q37294311 | Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli |
| Q40874006 | Cognate gene clusters govern invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri |
| Q37055410 | Common themes in microbial pathogenicity |
| Q33750518 | Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. |
| Q40149266 | Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers |
| Q34008614 | Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans |
| Q36947654 | Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium |
| Q36065692 | Construction of attenuated Salmonella typhimurium Strain expressing Helicobacter pylori conservative region of adhesin antigen and its immunogenicity |
| Q33725162 | Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice |
| Q34008449 | Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915. |
| Q35012637 | Contribution of proton-translocating proteins to the virulence of Salmonella enterica serovars Typhimurium, Gallinarum, and Dublin in chickens and mice. |
| Q72262596 | Coronavirus immunogens |
| Q36980585 | Correlation between the presence of sequences homologous to the vir region of Salmonella dublin plasmid pSDL2 and the virulence of twenty-two Salmonella serotypes in mice |
| Q40409409 | Current perspectives in salmonellosis |
| Q35909962 | Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae |
| Q35227904 | Cyclic AMP in prokaryotes |
| Q37647700 | DNA supercoiling and environmental regulation of gene expression in pathogenic bacteria |
| Q35210803 | Delivery of Antigens by Recombinant a Virulent Salmonella Strains |
| Q37599376 | Developing live vaccines against plague. |
| Q34548512 | Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. |
| Q33613680 | Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector. |
| Q35452874 | Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice |
| Q39519935 | Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha |
| Q35097492 | Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. |
| Q34004542 | Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin |
| Q35475498 | Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-Type Salmonella strains. |
| Q90533031 | Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr |
| Q34164581 | Elicitation of predictable immune responses by using live bacterial vectors |
| Q49339110 | Engineering bacteria for diagnostic and therapeutic applications |
| Q55085864 | Engineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery. |
| Q35665380 | Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge |
| Q34126431 | Essential role for cyclic AMP and its receptor protein in Yersinia enterocolitica virulence |
| Q35604978 | Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine |
| Q37062098 | Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. |
| Q37188845 | Evaluation of the respiratory route as a viable portal of entry for Salmonella in poultry via intratracheal challenge of Salmonella Enteritidis and Salmonella Typhimurium |
| Q33993351 | Evidence that expression of the Vibrio vulnificus hemolysin gene is dependent on cyclic AMP and cyclic AMP receptor protein |
| Q34003274 | Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain |
| Q40743996 | Fate of Salmonella enterica serovar Typhimurium on carrots and radishes grown in fields treated with contaminated manure composts or irrigation water |
| Q33877252 | Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice |
| Q41944370 | Further studies on the inhibition of colonization of the chicken alimentary tract with Salmonella typhimurium by pre-colonization with an avirulent mutant |
| Q36164100 | Growth regulation of a Salmonella plasmid gene essential for virulence |
| Q58719828 | HU-Lacking Mutants of Enteritidis Are Highly Attenuated and Can Induce Protection in Murine Model of Infection |
| Q50068766 | Heterologous protection in pigs induced by a plasmid-cured and crp gene-deleted Salmonella choleraesuis live vaccine. |
| Q57811561 | Host lipid sensing promotes invasion of cells with pathogenic Salmonella |
| Q34100373 | Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. |
| Q36947780 | Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium |
| Q35779035 | Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. |
| Q33756680 | Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant |
| Q33595640 | Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium. |
| Q34120949 | Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine |
| Q36363602 | Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes |
| Q40587937 | Immunogenicity of chi4127 phoP- Salmonella enterica serovar Typhimurium in dogs |
| Q42571053 | Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines |
| Q34469778 | Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule |
| Q43631937 | Intranasal immunogenicity of a Delta cya Delta crp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse |
| Q43604629 | Intranasal immunogenicity of a Deltacya Deltacrp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse |
| Q77798314 | Introduction to poultry vaccines and immunity |
| Q40428027 | Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis |
| Q37075381 | Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium |
| Q33748369 | Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin |
| Q40374003 | Light emission from a Mudlux transcriptional fusion in Salmonella typhimurium is stimulated by hydrogen peroxide and by interaction with the mouse macrophage cell line J774.2. |
| Q41074438 | Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice. |
| Q35689514 | Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system |
| Q27003066 | Live attenuated vaccines for invasive Salmonella infections |
| Q33921859 | Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen |
| Q28084076 | Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery |
| Q34581241 | Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enterica serovar typhimurium infection of mice. |
| Q50081378 | Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella |
| Q38456985 | Metabolic Regulation of a Bacterial Cell System with Emphasis on Escherichia coli Metabolism |
| Q33768215 | Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection. |
| Q36087007 | Molecular, functional, and evolutionary analysis of sequences specific to Salmonella |
| Q41445311 | Multiple Signals Govern Utilization of a Polysaccharide in the Gut Bacterium Bacteroides thetaiotaomicron. |
| Q36986693 | Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. |
| Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
| Q37674803 | New technologies in using recombinant attenuated Salmonella vaccine vectors |
| Q41300030 | Nonrecombinant and recombinant avirulent Salmonella vaccines for poultry |
| Q33862794 | Nonspecific cellular defense of the avian respiratory system: a review |
| Q47103827 | O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections |
| Q36718111 | Oral Delivery of Antigens in Live Bacterial Vectors |
| Q35532132 | Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain |
| Q35011130 | Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer |
| Q46504642 | Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens |
| Q36986366 | Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit |
| Q36985474 | Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus |
| Q35677333 | Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens |
| Q34521851 | Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. |
| Q35413101 | Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats |
| Q34532411 | Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats. |
| Q39548338 | Oral vaccination |
| Q33619067 | Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing O4,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4,5,12) |
| Q36947218 | Oral vaccination of weaned rabbits against enteropathogenic Escherichia coli-like E. coli O103 infection: use of heterologous strains harboring lipopolysaccharide or adhesin of pathogenic strains |
| Q36677790 | Outer membrane protein PhoE as a carrier for the exposure of foreign antigenic determinants at the bacterial cell surface |
| Q34000533 | Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses |
| Q41868219 | Physiological and Immunological Regulations in Caenorhabditis elegans Infected with Salmonella enterica serovar Typhi |
| Q38813137 | Plague Vaccines: Status and Future |
| Q37008636 | Plasmid-associated virulence of Salmonella typhimurium |
| Q36988512 | Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers |
| Q33731344 | Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines |
| Q35375735 | Progress towards development of a vaccine for amebiasis. |
| Q44432998 | Protective immune responses against protease-like antigens of the murine malaria parasite Plasmodium vinckei |
| Q37688618 | Rational considerations about development of live attenuated Yersinia pestis vaccines |
| Q40488602 | Rational design of Salmonella-based vaccination strategies |
| Q33826608 | Recent advances with recombinant bacterial vaccine vectors. |
| Q36002472 | Recombinant avirulent salmonellae as oral vaccine carriers |
| Q37451225 | Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen |
| Q50128777 | Regulation of host immune responses by modification of Salmonella virulence genes |
| Q31030619 | Resistance to host antimicrobial peptides is necessary for Salmonella virulence |
| Q33613555 | Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions |
| Q34334340 | Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice |
| Q35770624 | Role of intragenic binding of cAMP responsive protein (CRP) in regulation of the succinate dehydrogenase genes Rv0249c-Rv0247c in TB complex mycobacteria |
| Q35553394 | Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system |
| Q33755761 | Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model |
| Q43662382 | Safety and protective efficacy of live attenuated Salmonella Gallinarum mutants in Rhode Island Red chickens |
| Q36982528 | Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a |
| Q37144932 | Salmonella enterica serovar Typhimurium mutants unable to convert malate to pyruvate and oxaloacetate are avirulent and immunogenic in BALB/c mice |
| Q37099435 | Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo |
| Q34003465 | Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines |
| Q50105772 | Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors |
| Q34303992 | Salmonella typhimurium phoP virulence gene is a transcriptional regulator |
| Q35102292 | Salmonella typhimurium virulence in a burned-mouse model |
| Q37008201 | Salmonellae interplay with host cells |
| Q50078109 | Sensing by bacterial regulatory systems in host and non-host environments |
| Q48042402 | Sequence and functional analysis of the gene encoding Vibrio cholerae cAMP receptor protein |
| Q38235406 | Small RNA functions in carbon metabolism and virulence of enteric pathogens |
| Q36967546 | Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus |
| Q35778945 | Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin |
| Q35025547 | Technologies and approaches to elucidate and model the virulence program of salmonella |
| Q33756294 | The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infection |
| Q33589164 | The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases |
| Q40546686 | The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella |
| Q40732924 | The effect of exposure to a Δcya/ Δcrp mutant of Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain |
| Q42985403 | The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. |
| Q40375960 | The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors. |
| Q37955761 | The myriad roles of cyclic AMP in microbial pathogens: from signal to sword |
| Q33877406 | The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. |
| Q39930479 | The spv virulence operon of Salmonella typhimurium LT2 is regulated negatively by the cyclic AMP (cAMP)-cAMP receptor protein system |
| Q43604617 | The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis |
| Q35591407 | Transcriptional autoregulation of the Salmonella typhimurium phoPQ operon |
| Q36150381 | Type 1 fimbriae of Salmonella enteritidis |
| Q33410780 | Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP |
| Q40105597 | Use of Attenuated but Metabolically Competent Salmonella as a Probiotic To Prevent or Treat Salmonella Infection |
| Q31887727 | Use of live bacterial vaccine vectors for antigen delivery: potential and limitations |
| Q33694821 | Vaccination for control of Salmonella in poultry |
| Q50039335 | Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice |
| Q34543536 | Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate |
| Q33523808 | Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. |
| Q33933454 | Vaccine delivery to animals |
| Q34437680 | Vaccines against the avian enteropathogens Eimeria, Cryptosporidium and Salmonella. |
| Q36309415 | Vaccines against typhoid fever |
| Q69792665 | Vaccines for the Third World |
| Q33749723 | Virulence of a Salmonella typhimurium OmpD mutant. |
| Q33675781 | Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague |
Search more.